An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast

By Gottlieb A. B.   Strober B.   Krueger J. G.   Rohane P.   Zeldis J. B.   Hu C. C.   Kipnis C.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1529-1538

Informa Healthcare

Access to resources Recommend Favorite

Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis

By Reich Kristian   Sinclair Rodney   Roberts Graeme   Griffiths Christopher E. M.   Tabberer Maggie   Barker Jonathan  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1237-1254

Informa Healthcare

Access to resources Recommend Favorite

Correlation of Lesional Skin Corneometry Values with Serum E‐Selectin Levels and Disease Severity in Patients Affected by Plaque‐type Psoriasis: Recovery after Effective Therapy

By  

THE JOURNAL OF DERMATOLOGY, Vol. 22, Iss. 7, 1995-07 ,pp. : 475-479

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque‐type psoriasis severity and treatment efficacy for patients and clinicians

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 3, 2015-03 ,pp. : 498-506

John Wiley & Sons Inc

Access to resources Recommend Favorite

Coexistence of Plaque‐Type Blue Nevus and Congenital Melanocytic Nevi

By  

THE JOURNAL OF DERMATOLOGY, Vol. 23, Iss. 5, 1996-05 ,pp. : 325-328

John Wiley & Sons Inc

Access to resources Recommend Favorite